Blatt Lawrence
Aligos Therapeutics, Inc. · President and CEO
Blatt Lawrence is listed in public filings as director, officer: President and CEO. This Blatt Lawrence insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Aligos Therapeutics, Inc. (ALGS). Investors use Blatt Lawrence's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $744k105.8k shares | Grant / ExerciseMar 9, 2026 | $744.1K105.8k shares | $7.03 | -- |
Insider Trades History
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $1.6M179.8k shares | Grant / ExerciseJul 16, 2025 | $1.6M179.8k shares | $8.68 | -- | |
| $2.4M140.1k shares | Grant / ExerciseFeb 28, 2025 | $2.4M140.1k shares | $16.87 | -- | |
| $398k33.9k shares | Grant / ExerciseSep 4, 2024 | $398.2K33.9k shares | $11.74 | -- |